Mackenzie Financial Corp Emergent Bio Solutions Inc. Transaction History

Mackenzie Financial Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$33.11 - $55.01 $153,001 - $254,201	-4,621 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$50.07 - $66.05 $50,270 - $66,314	1,004 Added 27.76%	4,621 $231,000
Q2 2021 Aug 11, 2021	BUY	$56.61 - $80.46 $204,758 - $291,023	3,617 New	3,617 $228,000
Q3 2019 Nov 14, 2019	SELL	$40.6 - $57.2 $195,692 - $275,704	-4,820 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$39.92 - $53.86 $35,928 - $48,474	-900 Reduced 15.73%	4,820 $233,000
Q1 2019 May 15, 2019	BUY	$48.23 - $66.16 $275,875 - $378,435	5,720 New	5,720 $289,000
Q3 2018 Nov 15, 2018	SELL	$52.05 - $66.51 $6.23 Million - $7.96 Million	-119,689 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$48.33 - $55.64 $28,998 - $33,384	-600 Reduced 0.5%	119,689 $6.04 Million
Q1 2018 May 14, 2018	BUY	$44.44 - $54.39 $5.35 Million - $6.54 Million	120,289 New	120,289 $6.33 Million

159

33.7M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $473M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.